CareTrust REIT doubles credit facility to $1.2 billion

Published 12/19/2024, 08:10 PM
CTRE
-

SAN CLEMENTE, Calif. - CareTrust REIT, Inc. (NYSE:CTRE), a real estate investment trust company, has announced the renewal and doubling of its unsecured revolving credit facility to $1.2 billion, with a consortium of banks led by KeyBanc Capital Markets. The expansion of the credit facility is accompanied by an upgrade in the company's corporate rating by S&P Global Ratings to BB+ and an upgrade of its issue-level rating on unsecured notes to BBB-.

The credit facility is designed to support CareTrust's growth strategy, including future acquisitions. Chief Financial Officer Bill Wagner expressed satisfaction with the support from the banking partners, both longstanding and new, who are contributing to the company's growth potential. "This credit facility provides a vital means for financing future acquisitions of any size," Wagner stated.

The press release also includes forward-looking statements regarding the company's intentions and expectations for the future, which involve risks and uncertainties that could cause actual results to differ materially from projected outcomes. Based on InvestingPro's Fair Value analysis, the stock appears fairly valued at current levels. Factors that may affect the company's operations and prospects include tenant performance under leases, regulatory impacts on tenants, the ability to secure favorable acquisition opportunities, market access, interest rate fluctuations, and broader public health crises. The company maintains strong profitability with a 95.3% gross profit margin and has shown a solid return on invested capital of 8%.

CareTrust REIT specializes in the ownership, acquisition, development, and leasing of healthcare-related properties, including skilled nursing and senior housing facilities. The company operates nationwide, focusing on long-term net-leased properties and a growing portfolio of quality operators.

The press release also includes forward-looking statements regarding the company's intentions and expectations for the future, which involve risks and uncertainties that could cause actual results to differ materially from projected outcomes. Based on InvestingPro's Fair Value analysis, the stock appears fairly valued at current levels. Factors that may affect the company's operations and prospects include tenant performance under leases, regulatory impacts on tenants, the ability to secure favorable acquisition opportunities, market access, interest rate fluctuations, and broader public health crises. The company maintains strong profitability with a 95.3% gross profit margin and has shown a solid return on invested capital of 8%.

This news report is based on a press release statement from CareTrust REIT, Inc. and does not include speculative or forward-looking assessments beyond those provided by the company.

In other recent news, CareTrust REIT has been the subject of significant developments. The company was downgraded from an Outperform rating to Market Perform by BMO Capital Markets, following allegations surrounding PACS, a significant tenant contributing approximately 20% of CareTrust's pro-forma rents. This adjustment in stance comes with a new price target set at $32.00.

Despite this, CareTrust REIT reported strong financial performance in the third quarter of 2024, including a significant acquisition of skilled nursing facilities in Tennessee and the Northeast, totaling $557 million. The company's financial highlights include a 66% increase in normalized Funds From Operations (FFO) to $60.9 million and a 60% rise in normalized Funds Available for Distribution (FAD) to $61.9 million.

Furthermore, CareTrust raised its 2024 FFO per share guidance to $1.49-$1.50 and FAD per share guidance to $1.53-$1.54. The company also maintains a strong liquidity position with approximately $230 million in cash and plans to upsize its revolver to $1.2 billion. These recent developments underscore the dynamic environment in which CareTrust REIT operates.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.